Remove 2018 Remove BioTech Remove Digital Health Remove Medicare
article thumbnail

The Retail Health Battle Royale in the U.S. – A Week-Long Brainstorm, Day 2 of 5 – Amazon and One Medical

Health Populi

Goldman Sachs and Morgan Stanley put the deal together , with Morgan having led ONEM’s acquisition of Iora Health last year. Iora Health has focused on the Medicare-enrolled population, distinct from ONEM’s target patient market of younger, employed consumers. bn and MGM Studios for $8.5 bn and MGM Studios for $8.5

article thumbnail

The Evolution of Self-Care for Consumers – Learning and Sharing at CHPA

Health Populi

For the organization’s 2020 vision, there are three category pillars in sight: over-the-counter (OTC) drugs (the core mission for over a century), dietary supplements, and consumer medical devices (think: the CES digital health aisles, and beyond). Consumer health as a category was $45 billion in 2018, growing at 2.1%.

BioTech 149
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

I’m glad to be getting back to health economic issues after spending the last couple of weeks firmly focused on consumers, digital health technologies and CES 2019. There’s a lot for me to address concerning health care costs based on news and research published over the past couple of weeks.

BioTech 160
article thumbnail

Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports

Health Populi

In 2018, spending on branded prescription drugs will fall in wealthy countries, while spending on specialty drugs will increase, resulting in flat medicines spending. Specifically, $19 billion worth of biotech spending will find biosimilar competition starting in 2018 for the first time. In the U.S.,